Kelei Su

549 total citations
23 papers, 393 citations indexed

About

Kelei Su is a scholar working on Complementary and alternative medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Kelei Su has authored 23 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Complementary and alternative medicine, 7 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in Kelei Su's work include Traditional Chinese Medicine Studies (6 papers), Medicinal Plants and Bioactive Compounds (4 papers) and Pharmacological Effects of Natural Compounds (3 papers). Kelei Su is often cited by papers focused on Traditional Chinese Medicine Studies (6 papers), Medicinal Plants and Bioactive Compounds (4 papers) and Pharmacological Effects of Natural Compounds (3 papers). Kelei Su collaborates with scholars based in China, United States and United Kingdom. Kelei Su's co-authors include Xingjiang Xiong, Pengqian Wang, Yanwei Xing, William C. Cho, Peng Cao, Wei Liu, Chunping Hu, Lian Duan, Juan Ye and Xiaoke Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and CHEST Journal.

In The Last Decade

Kelei Su

22 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kelei Su China 11 134 118 79 63 49 23 393
Jiang Liang-duo China 8 67 0.5× 121 1.0× 71 0.9× 40 0.6× 30 0.6× 19 331
Qi Bao China 9 159 1.2× 84 0.7× 50 0.6× 36 0.6× 48 1.0× 17 370
Hee-Jae Jung South Korea 12 116 0.9× 81 0.7× 49 0.6× 105 1.7× 73 1.5× 64 405
Shenghui Zhao China 10 168 1.3× 77 0.7× 69 0.9× 14 0.2× 22 0.4× 14 362
Lian‐Di Kan China 9 105 0.8× 68 0.6× 54 0.7× 123 2.0× 23 0.5× 18 332
Yucong Shi China 15 182 1.4× 45 0.4× 64 0.8× 63 1.0× 18 0.4× 24 440
Liyun Duan China 11 142 1.1× 92 0.8× 66 0.8× 21 0.3× 15 0.3× 21 363
Morio Hosoi Italy 10 89 0.7× 58 0.5× 33 0.4× 43 0.7× 38 0.8× 61 429
Öztekin Çıkman Türkiye 9 95 0.7× 66 0.6× 27 0.3× 44 0.7× 33 0.7× 25 446

Countries citing papers authored by Kelei Su

Since Specialization
Citations

This map shows the geographic impact of Kelei Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelei Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelei Su more than expected).

Fields of papers citing papers by Kelei Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelei Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelei Su. The network helps show where Kelei Su may publish in the future.

Co-authorship network of co-authors of Kelei Su

This figure shows the co-authorship network connecting the top 25 collaborators of Kelei Su. A scholar is included among the top collaborators of Kelei Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelei Su. Kelei Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gu, Chao, Jin Xu, Kelei Su, et al.. (2025). Diagnostic and prognostic values of tsRNAs in lung cancer: a meta-analysis. BMC Cancer. 25(1). 153–153. 1 indexed citations
2.
Meng, Hao, Jin Xu, Fang Long, et al.. (2025). Synergistic anticancer effects of carrier-free self-assembled doxorubicin and emodin nanoparticles in non-small cell lung cancer. Scientific Reports. 15(1). 40205–40205.
3.
Zhang, Yeqing, et al.. (2024). Protective effect of Astragaloside II against lung injury in COPD based on mTORC1/GSK-3β signaling pathway. European Journal of Pharmacology. 988. 177214–177214. 1 indexed citations
4.
Zhang, Xiaoyu, Kelei Su, Erxin Shang, et al.. (2024). Network pharmacology analysis and experimental verification of the antithrombotic active compounds of trichosanthis pericarpium (Gualoupi) in treating coronary heart disease. Journal of Ethnopharmacology. 329. 118158–118158. 5 indexed citations
5.
Liu, Pei, Xiao-Ying Tan, Kelei Su, et al.. (2023). Optimal compatibility proportional screening of Trichosanthis Pericarpium - Trichosanthis Radix and its anti - Inflammatory components effect on experimental zebrafish and coughing mice. Journal of Ethnopharmacology. 319(Pt 1). 117096–117096. 12 indexed citations
6.
Zheng, Jiazhen, Yingchai Zhang, Kelei Su, et al.. (2022). Preserved Ratio Impaired Spirometry in Relationship to Cardiovascular Outcomes. CHEST Journal. 163(3). 610–623. 36 indexed citations
7.
Ye, Juan, Kelei Su, Yuehua Xu, et al.. (2022). Effect of Salivary Antimicrobial Factors on Microbial Composition of Tongue Coating in Patients with Coronary Heart Disease with Phlegm-Stasis Syndrome. World Journal of Traditional Chinese Medicine. 8(1). 123–130. 3 indexed citations
8.
Xia, Xiaopeng, et al.. (2021). Bugan Rongjin decoction alleviates inflammation and oxidative stress to treat the postmenopausal knee osteoarthritis through Wnt signaling pathway. BioMedical Engineering OnLine. 20(1). 103–103. 10 indexed citations
9.
Su, Kelei & Xingjiang Xiong. (2021). [Treatment strategy and thought on classical herbal formulae for coronavirus disease 2019].. China Journal of Chinese Materia Medica. 46(2). 494–503. 10 indexed citations
10.
Hua, Di, Jie Yang, Qinghai Meng, et al.. (2021). Soufeng sanjie formula alleviates collagen-induced arthritis in mice by inhibiting Th17 cell differentiation. Chinese Medicine. 16(1). 39–39. 16 indexed citations
11.
12.
Xiong, Xingjiang, Pengqian Wang, Kelei Su, William C. Cho, & Yanwei Xing. (2020). Chinese herbal medicine for coronavirus disease 2019: A systematic review and meta-analysis. Pharmacological Research. 160. 105056–105056. 112 indexed citations
13.
Xiong, Xingjiang, Pengqian Wang, Lian Duan, et al.. (2019). Efficacy and safety of Chinese herbal medicine Xiao Yao San in hypertension: A systematic review and meta-analysis. Phytomedicine. 61. 152849–152849. 37 indexed citations
14.
Xiong, Xingjiang, et al.. (2019). [Application of cream formula in treatment of severe heart failure].. PubMed. 44(18). 3903–3907. 3 indexed citations
15.
Xu, Tingting, Kelei Su, Chi Wang, et al.. (2017). Investigation of therapeutic effect of Longchai Formula Granule on chronic hepatitis B patients: A double-blind, controlled and randomized clinical trial. SHILAP Revista de lepidopterología. 8. 1029–1029. 1 indexed citations
16.
Ye, Juan, Xueting Cai, Chunping Hu, et al.. (2016). Bacillus as a potential diagnostic marker for yellow tongue coating. Scientific Reports. 6(1). 32496–32496. 39 indexed citations
17.
Wang, Zhigang, Xueting Cai, Dawei Wang, et al.. (2016). Yupingfeng Pulvis Regulates the Balance of T Cell Subsets in Asthma Mice. Evidence-based Complementary and Alternative Medicine. 2016(1). 6916353–6916353. 18 indexed citations
18.
19.
Su, Kelei, et al.. (2013). Retrospective study on Professor Zhongying Zhou's experience in Traditional Chinese Medicine treatment on diabetic nephropathy. Journal of Traditional Chinese Medicine. 33(2). 262–267. 18 indexed citations
20.
Xiong, Xingjiang, Xiaochen Yang, Bo Feng, et al.. (2013). Zhen Gan Xi Feng Decoction, a Traditional Chinese Herbal Formula, for the Treatment of Essential Hypertension: A Systematic Review of Randomized Controlled Trials. Evidence-based Complementary and Alternative Medicine. 2013. 1–9. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiang Liang-duo Breakdown of academic impact, for papers by Qi Bao Breakdown of academic impact, for papers by Hee-Jae Jung Breakdown of academic impact, for papers by Shenghui Zhao Breakdown of academic impact, for papers by Lian‐Di Kan Breakdown of academic impact, for papers by Yucong Shi Breakdown of academic impact, for papers by Liyun Duan Breakdown of academic impact, for papers by Morio Hosoi Breakdown of academic impact, for papers by Öztekin Çıkman
Rankless by CCL
2026